Metabolism Open

Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study)

By Ambrish C., Anurag Ranjan Kundan Lal Lila, Archit Parikh, Vinob Kalkoti

Randomised trial in 223 peopleInterventions

24 weeks, multicentre, registered CTRI-2025-06-089290

The paper

Medstar Speciality Hospital; Intas Pharmaceuticals (India)

Metabolism Open, 5 Aug 2026

doi.org/10.1016/j.metop.2026.100489 PubMed 42598626

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety